Nick Cannon doubles down on feud with Eminem with a SECOND diss track
Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Flair also analysed dozens of open letters published by alumnae of private schools who complained last year about racist abuse…